Peter Schulam, MD, PhD


Dr. Peter Schulam is the inaugural chair of the Department of Urology at the Yale School of Medicine and co-founder of the Yale Center for Biomedical Innovation and Technology (CBIT). Dr. Schulam joins Yale from the Ronald Reagan Medical Center at the University of California at Los Angeles, where he was Vice Chair of Urology, Chief of the Division of Endourology and Minimally Invasive Surgery, and Director the Surgical Living Kidney Donor Program.

Dr. Schulam is a graduate of the NIH-funded Medical Scientist Training Program at Baylor College of Medicine and received his PhD in Immunology in 1990 and his MD in 1992. He then trained in Surgery as an intern and assistant resident from 1992-94 and in Urology as a resident from 1994-98 at Johns Hopkins Hospital.

Dr. Schulam has been very active in medical device development. He has been an advisor to Computer Motion, Intuitive Surgical, Karl Storz, ACMI and Cook. He is currently a scientific advisor to SurgiQuest, Suture Ease and MedicaMetrix. In addition, he holds the patent for the second-generation ureteroscope that is now the standard in urologic endoscopy.

While at UCLA, he founded the Center for Advanced Surgical and Interventional Technology (CASIT) for the development of next-generation surgical technology and for the enhancement of surgical education and training. It is because of this passion for improving patient care through the advancement of medical technology that he co-founded CBIT at Yale with Dr. Mark Saltzman.

Mark Saltzman, PhD


Prof. Mark Saltzman is a co-founder of the Center for Biomedical Innovation and Technology (CBIT) at Yale, and is also the Chair of Biomedical Engineering, the Goizueta Foundation Professor of Biomedical Engineering, Chemical & Environmental Engineering, and Physiology. Dr. Saltzman has been recognized widely for his excellence in research and teaching. His work in drug delivery, biomaterials, nanobiotechnology, and tissue engineering have been described in over 250 research papers and patents. He is also the sole author of three textbooks: Biomedical Engineering (2009), Tissue Engineering (2004), and Drug Delivery (2001). 

Dr. Saltzman has received the Camille and Henry Dreyfus Foundation Teacher-Scholar Award (1990); the Allan C. Davis Medal as Maryland's Outstanding Young Engineer (1995); the Controlled Release Society Young Investigator Award (1996); and the Professional Progress in Engineering Award from Iowa State University (2000). He has been honored by election as a Fellow of the American Institute for Medical and Biological Engineering (1997); a Fellow of the Biomedical Engineering Society (2010); a Member of the Connecticut Academy of Science & Engineering (2012); and a Fellow of the National Academy of Inventors (2013). He has delivered over 200 invited lectures throughout the world including the Britton Chance Distinguished Lecture in Engineering and Medicine at the University of Pennsylvania (2000) and the Distinguished Lecture of the Biomedical Engineering Society (2004).

Chris Loose, PhD

Co-Executive Director

Dr. Loose serves as Executive Director of CBIT, while holding an appointment as Associate Professor Adjunct in Urology at Yale University. He is also an Accelerator Executive at the Center for Integration of Medicine and Innovative Technology (CIMIT).

In 2006, Dr. Loose co-founded Semprus BioSciences with Massachusetts Institute of Technology (MIT) Institute Professor Robert Langer and David Lucchino, and served as Chief Technology Officer until the company was acquired by Teleflex Incorporated in 2012 (TFX: $80M).  A peer-review of the Semprus Technology was published in Science Translational Medicine and received a Frost and Sullivan Breakthrough Technology Award in 2010.  Semprus’ first product, a vascular catheter with a surface modification designed to have reduced thrombus (clot) formation, was FDA-cleared in 2012.

Dr. Loose received the prestigious Hertz Foundation Fellowship and was selected by MIT’s Technology Review as a member of the “TR35,” naming the world's top 35 innovators under the age of 35. He was awarded the inaugural Peter Strauss Entrepreneurial Award from the Hertz Foundation in 2011 and was also named to Boston Business Journal's 40 emerging business leaders under 40.  

While earning his PhD. in Chemical Engineering at MIT, Dr. Loose co-authored the Semprus Biosciences business plan which won entrepreneurial competitions at MIT, Harvard University and Oxford University.  Prior to his graduate work, Dr. Loose was a chemical engineer at Merck Research Labs after graduating summa cum laude with a B.S.E in Chemical Engineering from Princeton University.

Mike Dempsey

Michael K. Dempsey

Co-Executive Director

Mike Dempsey has been working in the field of medical devices for more than 30 years; during this time he has invented or worked on products that have treated over twelve million people. Mike holds over 40 patents on various medical devices and has ten more patents pending. Mike is currently the founder and CEO of Secora.Care, an early-stage company that uses “Big Data” to help older people live safely at home as long as possible. 

Mike is also the Entrepreneur in Residence at the Center for the Integration of Medicine and Innovative Technology (CIMIT), the Director of the CIMIT Accelerator Program, the Co-Executive Director of the Center for Biomedical Innovation and Technology (CBIT) at Yale University, and a faculty member at MIT. Mike’s primary responsibilities in these academic settings are to lead academic innovators through the commercialization journey and to teach students the fundamentals of building medical companies. At CIMIT and Yale, Mike leads a team of highly experienced med-tech executives who join the academic team with up to a full-time commitment and for as long as two years, effectively acting as an interim CEO. This intensive, practical, and focused approach to facilitating the academic-to-commercial transition has led to a commercialization success rate of 42% and an average time to commercialize of 18 months. Mike is also the PI on several NIH SBIR grants, a frequent grant reviewer for the NIH, and has received a special citation from the Commissioner of the FDA for "exceptional initiative and leadership to protect the public health."

Ayesha Khalid

Ayesha Khalid, MD, MBA

Clinical Director

Ayesha is an Ear, Nose and Throat (ENT) surgeon at Harvard Medical School with over 10 years of experience in the healthcare industry. She is an endoscopic sinus surgeon and performed cutting edge basic science research at the University of Pennsylvania. She worked to set up the satellite practice for The Massachusetts  Eye and Ear Infirmary at Emerson Hospital in Concord, Massachusetts. Recently, Ayesha completed a fulltime mid-career MBA in Global Leadership and Innovation from the MIT Sloan School of Management.

Ayesha has combined her medical expertise and innovation experience to apply a systems thinking approach to solving healthcare problems as shown in her TedX talk. Ayesha joined MIT Hacking Medicine and has been helping to promote disruptive thinking in healthcare through organized events in Doha, Qatar, BIO 2014 and MIT. 

Ayesha has also served as a consultant at Lambay Advisors and worked with private equity firms on understanding market dynamics and business opportunities in the senior living space, health IT and the opportunities for practice management. As a practicing surgeon, Ayesha understands the healthcare change process and the need to foster cross-disciplinary engagement. Ayesha has served as the Vice-President of Business Development of a start-up focused on changing the surgical conversation with patients, Doctella. On a national level, Ayesha serves as an executive member on several Boards for medical organizations and is currently on the board of the American Academy of Otolaryngology- Head and Neck Surgery. 

Recently, Ayesha has joined the CBIT team at Yale to increase clinician engagement. Given that Ayesha bridges the gap between management and medicine, she is enthusiastic to support projects as they come through the CBIT ecosystem. She is currently co-teaching Creating Healthcare and Life Sciences Ventures with Dr. Loose at the Yale School of Management.

Margaret Cartiera

Margaret Cartiera, PhD

Investment and Innovation Director

Dr. Margaret Cartiera has worked at the intersection of science and business for more than 15 years. Roles in investment, competitive intelligence, regulatory affairs and management have given her a unique perspective on the innovation life cycle, shifts in the bioscience industry, and the potential of what is to come.

Throughout her professional career, Dr. Cartiera has built a reputation for developing effective business strategies, forming solid partnerships, and solving problems creatively. She currently serves as the Investment and Innovation Manager at Yale University’s Center for Biomedical Innovation and Technology (CBIT), where she works in close collaboration with Yale New Haven Hospital. During her time as Vice President and Fund Manager at Connecticut Innovations, Dr. Cartiera managed the Regenerative Medicine Research Fund and Connecticut’s pioneering $200M Bioscience Innovation Fund.

Dr. Cartiera earned her B.S. in Biomedical Engineering at Rensselaer Polytechnic Institute in Troy, NY. While there, she learned about the fundamentals of science, as well as its rigors, which fueled her to pursue her graduate degree. She caught the innovation bug while pursuing her Master of Science degree at the University of Pennsylvania, where her studies focused on translating innovation from bench to bedside, and led to her desire to work in the startup community. Dr. Cartiera completed her formal training in biomedical engineering with doctoral studies at Yale University.

Dr. Cartiera has embraced living at the intersection of the business and scientific worlds—understanding the novelty and promise that only scientific discovery can bring, while also appreciating the challenges of fundraising, the pains of company growth, the hurdles of FDA regulation, and the unpredictability of the markets. In her spare time, Dr. Cartiera mentors young inventors and entrepreneurs working at the earliest stages of commercialization.


Michelle Nantel - Operations and Program Manager